PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
This is a continuing activity from FY 2008. No narrative required.
New/Continuing Activity: Continuing Activity
Continuing Activity: 12806
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
12806 4832.08 HHS/Centers for Columbia 6307 129.08 Columbia MCAP $883,908
Disease Control & University Supplement
Prevention Mailman School of
Public Health
7179 4832.07 HHS/Centers for Columbia 4329 129.07 Columbia MCAP $626,843
4832 4832.06 HHS/Centers for Columbia 2572 129.06 Columbia MCAP $250,000
Emphasis Areas
Gender
* Increasing gender equity in HIV/AIDS programs
Health-related Wraparound Programs
* Child Survival Activities
* Family Planning
* Malaria (PMI)
* Safe Motherhood
* TB
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $579,731
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.01:
ACTIVITY UNCHANGED FROM FY 2008:
In FY 2008, Columbia/ICAP will be providing BCS services to 28,000 PLHIV at 46 sites. BCS services in FY
2009 will continue at the existing 46 sites and be initiated at the 10 stand alone FY 2008 PMTCT sites.
Services supported will include, clinical staging and baseline CD4 count for all patients, follow-up CD4 every
six months, management of OIs and other HIV-related illnesses, including OI diagnosis and treatment, and
routine provision of CTX prophylaxis for eligible adults, children and exposed infants based on national
guidelines, basic nutritional counseling and support, positive living and risk reduction counseling, pain and
symptom management, and end-of-life care. In addition, ICAP will continue to provide psychosocial
counseling including counseling and referrals for HIV-infected female victims of domestic violence. To
ensure comprehensive services across a continuum, ICAP, through the partnership with CHAMP and other
community services providers, refers patients enrolled in care to community-based BCS services based on
their individual need, including adherence counseling, spiritual support, stigma-reducing activities, OVC
support, IGA activities, and HBC services for end-of-life care. Through SCMS, ICAP will continue to provide
diagnostic kits, CD4 tests, and other exams for clinical monitoring, and will work with SCMS for the
appropriate storage, stock management, and reporting of all OI-related commodities.
In FY 2009, ICAP will expand its services to provide BCS to 32,646 existing patients and add an additional
5,656 new patients at 46 existing sites and 10 new sites. Expanded services will emphasize on quality of
care, continuum of care through effective linkages and referrals, and sustainability of services through PBF.
Strengthened nutritional services through training and provision of nutritional care will include counseling,
nutritional assessments using anthropometric indicators, and management of malnutrition through provision
of micronutrient and multivitamin supplements, and links to Title II food support for clinically eligible PLHIV
and children in line with national nutrition guidelines. ICAP will also support referrals for all PLHIV and their
families, particularly children under 5 and pregnant women, for malaria prevention services, including
provision of LLINs, in collaboration with CHAMP, GFATM and PMI; and referral of PLHIV and their families
to CHAMP CBOs and other community-service providers for distribution of water purification kits and health
education on hygiene, for reduction of diarrheal disease. In addition, family planning education, counseling
and methods will be provided to PLHIV and their spouses. This service will be located within the counseling
unit of the site to reduce need for referrals. Strengthened psychological and spiritual support services for
PLHIV at clinic and community levels will be done through expanded TRAC training in psychological
support for all Columbia-supported health facilities and community-based providers, including GBV
counseling, positive living, and counseling on Prevention for Positives.
In addition the Ministry of Health will implement a new community health policy in FY 2008. The policy calls
for the election of male and female leaders for every 100 households to lead community health activities,
organize other community volunteers into associations and supervise their activities. Columbia will support
56 health facilities to retrain, equip, and supervise 20 community health leads per health facility, in addition
to other health care workers, reaching a total of 1,254 health workers trained. These community health
workers will organize periodic meetings to ensure quality and coverage of community-based HIV services
and linkages between community and facilities. The facility-based case managers, community health leads
and community based services providers constitute an effective system that ensures continuum, coverage
and quality of basic and support care.
In order to ensure continuum of HIV care, Columbia in collaboration with CHAMP, will recruit case
managers at each of the supported sites. These case managers, with training in HIV patient follow-up, will
ensure referrals to care services for pediatric patients identified through PMTCT programs, PLHIV
associations, malnutrition centers, and OVC programs. To do this, the case managers will have planning
sessions with facilities and community-based service providers and OVC services providers for more
efficient use of patient referrals slips to ensure timely enrollment in care and treatment for children
diagnosed with HIV/AIDS. Columbia -supported sites will assess individual PLHIV needs, organize monthly
clinic-wide case management meetings to minimize follow-up losses of patients, and provide direct
oversight of community volunteers. The community volunteers will be organized in associations motivated
through community PBF based on the number of patients they assist and quality of services provided.
Columbia will work with CHAMP and its own Peer Educators for Adherence, Referral, and Linkages
(PEARL) program to develop effective referral systems between clinical care providers and psycho-social
and livelihood support services, through the use of patient routing slips for referrals and counter referrals
from community to facilities and vice versa. Depending on the needs of individuals and families, health
facilities will refer PLHIV to community-based HBC services, adherence counseling, spiritual support
through church-based programs, stigma reducing activities, CHAMP-funded OVC support, IGA activities
(particularly for PLHIV female and child-headed households), legal support services, and community-based
pain management and end-of-life care in line with national palliative care guidelines.
Increasing pediatric patient enrollment is a major priority for all PEPFAR clinical partners in FY 2008. To
expand quality pediatric care, Rwanda has few available pediatricians will train other clinical providers,
using the innovative model developed in FY 2006 and continuing in FY 2007 and FY 2008. Columbia will
support health facilities to refer HIV-infected children to OVC programming for access to education, medical,
social and legal services. Columbia will also support sites to identify and support women who may be
vulnerable when disclosing their status to their partner, and include in counseling the role of alcohol in
contributing to high-risk behaviors. Case managers will conduct regular case reviews with other partners
included in the referral system to review the effectiveness of the system, identify challenges and design
common strategies to overcome any barrier to pediatric patients routing between services. In addition, adult
patients enrolled in care will be encouraged to have their children tested and infected ones taken to HIV
care and treatment sites.
PBF is a major component of the Rwanda PEPFAR strategy for ensuring long-term sustainability and
maximizing performance and quality of services. In coordination with the HIV PBF project, Columbia will
shift some of their support from input to output financing based on sites' performance in improving key
national HIV performance and quality indicators. Full or partially reduced payment of BCS and other
indicators is contingent upon the quality of general health services as measured by the score obtained using
Activity Narrative: the standardized national Quality Supervision tool.
In the context of decentralization, DHTs now play an increasingly important role in the oversight and
management of clinical and community service delivery. Columbia will strengthen the capacity of four DHTs
to coordinate an effective network of BCS and other HIV/AIDS services. The basic package of financial and
technical support includes staff for oversight and implementation, transportation, communication, training of
providers, and other support to carry out key responsibilities.
This activity addresses the key legislative areas of gender, wrap around for food, microfinance and other
activities, and stigma and discrimination through increased community participation in care and support of
PLHIV.
Continuing Activity: 12809
12809 2799.08 HHS/Centers for Columbia 6307 129.08 Columbia MCAP $1,285,846
7177 2799.07 HHS/Centers for Columbia 4329 129.07 Columbia MCAP $454,300
2799 2799.06 HHS/Centers for Columbia 2572 129.06 Columbia MCAP $300,000
Estimated amount of funding that is planned for Human Capacity Development $200,000
Table 3.3.08:
THIS IS A CONTINUING ACTIVITY FROM FY 2008, ALREADY APPROVED
Continuing Activity: 12812
12812 2798.08 HHS/Centers for Columbia 6307 129.08 Columbia MCAP $742,721
7176 2798.07 HHS/Centers for Columbia 4329 129.07 Columbia MCAP $835,350
2798 2798.06 HHS/Centers for Columbia 2572 129.06 Columbia MCAP $3,189,000
Table 3.3.09:
THIS IS A CONTINUING ACTIVITY FROM FY 2008.
ICAP is one of the USG partners providing HIV care and treatment services for HIV-infected adults and
children in Rwanda. At present, the program has 56 sites in 9 districts. Of these facilities 32 provide
PMTCT (22 alongside with ART and 10 standalone), 42 provide ART for adults and for children. 2 provide
treatment for Adults alone and 41 have VCT, PMTCT and ART (for adults and children) co-located in the
same premises. These facilities are located in 9 districts of the 2 region of Rwanda. In FY2008, ICAP
provided a comprehensive package of basic care and support services to 4000 HIV-infected children and
treatment to 2492, at 46 sites. This package of services, is provided in collaboration with local community
service providers and includes, co-trimoxazole prophylaxis, nutrition counseling and food support,
insecticide treated nets (ITN) and safe water interventions. In addition, ICAP provides follow-up services for
HIV-exposed infants who are followed-up and maintained on co-trimoxazole prophylaxis until confirmation
of their HIV status can be obtained. For FY2009, ICAP will continue to provide the same package to 4000
old HIV-infected children and 400 new ones at its 46 existing sites. ICAP will also increase treatment
services for 242 new children at 46 existing sites to reach a total of 4400 of children in care and 2734 of
children on ART by end of FY09.
To address the need to expand diagnosis of HIV in the pediatric population ICAP will increase testing for
targeted pediatric populations within the catchment area of its existing sites. Using each HIV adult patient
enrolled in care and treatment at ICAP-supported sites, as an index case, ICAP will offer HIV-testing for
their partners and children and enrolls the infected family member/s into care and treatment services. ICAP-
supported sites will link with OVC service providers operating in its supported districts to offer HIV testing
services for children and their families, according to national guidelines, and ensure enrollment of HIV-
infected children into care and treatment services. ICAP, has been instrumental in initiating an approach to
test families as a means to identify HIV infected children and other adults in the household who would
benefit of early care interventions. In addition, ICAP-supported sites will link with malnutrition and TB
centers within their facilities or at specialized sites located in the vicinity to provide HIV testing to all
pediatric in- and out-patients and enroll the infected children into care and treatment services. ICAP will also
work to establish and strengthen linkages with PLHIV associations in the local network, and the
administrative district authorities and health teams to support activities to increase awareness in
communities on issues related to pediatric HIV to increase pediatric HIV testing and enrollment into care.
At PMTCT sites, enhanced follow-up of mothers and exposed infants will be promoted through support
groups of HIV-infected women based on the mother-to-mother model. In this model, women who
demonstrate steady consultation attendance and good baby care are identified and used to coach new HIV-
positive mothers during pregnancy and after delivery to ensure that both women and their infants access
needed services. During these groups sessions ICAP will provide ITNs, nutrition counseling, enhancing
family food support through training for improved home gardening and animal breading techniques, and
provide food supplementation to mother infant pairs. This last activity is conducted in collaboration with a
Prime PEPFAR funded Community Partner, the World Food Program (WFP), and the
CRS/ACDIVOCA/World Vision consortium. In addition, ICAP-supported sites will provide health education
on safe water and provision of water purification products. HIV-exposed infants identified at PMTCT sites
will be followed in the context of existing MCH services offered at existing ICAP sites. Mother and infant
information will be transferred from PMTCT to other MCH programs through the "carte de liaison" currently
in use in Rwanda as a means to transfer relevant HIV information between PMTCT and MCH programs.
Early infant diagnosis services, now available at 43 of ICAP supported sites, will be expanded to increase
full coverage of sites by end of FY09. EID will be offered at six weeks of age and at later ages for
symptomatic infants less than 18 months of age according to the national algorithm. ICAP will also work
with the district health teams to ensure that samples collected at the sites are transferred efficiently to the
processing lab at the National Reference Laboratory in Kigali and work with the MoH to increase reliability
of result turn-around times.
At ICAP-supported sites HIV-infected children will be staged clinically and using CD4 (counts or
percentages as these become available) and eligible infants and children will be enrolled in ART. ICAP will
work with other clinical implementing partners and the MoH to train health care providers on newly updated
pediatric HIV treatment guidelines which include changes for early treatment of HIV-infected infants and
changes in CD4 thresholds for treatment initiation of children between 36 and 59 months of age.
Systematic chart reviews to identify children now eligible for treatment based on new CD4 cut-offs will be
initiated in FY08.
All pediatric patients will have regular anthropometric evaluations to identify early signs of malnutrition and
ensure prompt initiation of nutrition rehabilitation interventions. Newly identified patients will be screened at
enrollment and at regular intervals for signs and symptoms of common opportunistic infections or other
infectious complications of HIV in children, including: candidiasis, pneumonia, malaria, meningitis, and PCP.
In addition, all pediatric patients will be screened for TB at enrolment and at each follow up visit using the
set of 5 questions developed by PNILT. Children suspected of having TB will be further investigated and
put on TB treatment or INH prophylaxis if infection or exposure is confirmed based on current national
guidance. Additionally, infants and children on ART will also be assessed at each visit for issues related to
adverse events, toxicity and adherence to ART. Staff will be trained to ensure, as much as possible, the
early detection of signs of immunologic and clinical failure and initiation of second line treatment regimens
based on national guidance.
Because HIV-exposed, infected and affected children do not have the same level of vulnerability and risk of
death as non-infected or affected population ICAP will work to implement a system to assess vulnerability
and will conduct home visits for families with HIV-infected children in order to identify and manage
accordingly those that need special attention.
Pediatric HIV care and treatment programs in Rwanda face many challenges, including the need for
increased numbers of qualified trained pediatric health care providers. ICAP will ensure that site-level
providers are trained or receive refresher training session in pediatric HIV patient management, according
Activity Narrative: to national guidelines. Providers will receive regularly planned in-service trainings and coaching sessions.
In collaboration with ICAP, and TRAC-plus, ICAP has dedicated staff to be part of the national mentoring
team, who will provide continued mentoring to clinical staff at ICAP supported sites in addition to national
level mentoring. Mentor staff will, in turn, train hospital and health center service providers in pediatric
clinical HIV care, palliative care, patient record-keeping, data recording and use, and quality performance
measurement and improvement. ICAP will continue to promote staff retention and motivation at supported
sites through innovative ways including continued training for individual staff skills development and offering
continuous technical support to successfully implement a performance-based financing model of service
delivery which provides staff bonus awards to high scoring sites.
Through work with the Supply Chain Management System (SCMS) and CAMERWA, the national
pharmaceutical warehouse, the district-level pharmacy,, the National Reference Laboratory (NRL) and the
regional laboratory network, ICAP will ensure training of health service providers on HIV opportunistic
infections, drug and reagent stock management and distribution, adherence counseling, good pharmacy
record-keeping and data use. ICAP will collaborate with health facilities to survey energy needs for proper
operation of laboratories, IT equipment and storage facilities. Sites in need of back-up or extended power
supplies will be equipped with solar-based energy sources.
In FY08, ICAP has worked closely with TRAC-plus to implement a mentoring program to train health care
providers in adult and pediatric HIV and HIV/TB management. This program will continue in FY09 to
support the building of capacity at site and district level to provide quality clinical services for children. 102
health care providers (4 from each of the 9 DHs and 2 from each of the 33 HCs) from 42 sites at 9 districts
will receive training through this mentorship program, this is more fully described under the UTAP supported
activities with Columbia University. Efforts to rapidly disseminate and begin implementation of new
treatment guidelines for infants and children will be greatly supported through this effort. In addition AIDS
Relief will continue to train managers and health service providers in the use of patients' data software.
Pediatric HIV care indicators will be linked to PMTCT indicators in the database for better follow-up of
infants exposed to HIV. With improved data on pediatric HIV care, ICAP, in collaboration with TRAC-plus,
the national performance-based program, and the HIVQUAL project will support health facilities to build and
sustain a system of quality performance measurement, improvement. This system will use basic pediatric
HIV care and support and treatment data as a source to regularly review program performance and
design/implement appropriate interventions to improve the quality of services provided to children and their
families. ICAP staff in charge of each district will ensure that meetings to review internal data take place on
a regular basis and that the improvement plan is implemented at individual sites. Yearly, district-level
meetings are planned where each facility will share their performance data and improvement strategies.
ICAP will ensure that pediatric HIV care is integrated with adult HIV care and that the family approach is
reinforced
Estimated amount of funding that is planned for Human Capacity Development $267,255
Table 3.3.10:
Estimated amount of funding that is planned for Human Capacity Development $82,819
Table 3.3.11:
ACTIVITY UNCHANGED FROM FY 2008.
In FY 2008, Columbia continued to implement the national TB/HIV policy and guidelines at 44 ICAP
supported sites including 2 state prisons. The program's achievements include at least 97% of all patients
with TB were tested for HIV, 88% of al dually infected patients received cotrimoxazole preventive therapy
and 44% received ART. At 44 MCAP-supported HIV care and treatment sites, 91% of patients newly
enrolled in HIV care were screened for TB. 71% of patients in care were routinely screened for TB during
follow up visits.
In FY 2009, Columbia will continue to support 44 existing sites and add 2 new sites for the implementation
of the TB/HIV component of the clinical package of HIV care. The priority in FY 2009 will be to expand
implementation of regular TB screening for all PLHIV, and for those suspected to have active TB, ensuring
adequate diagnosis and complete treatment with DOTS. Initial uptake and quality of TB screening activities
has been variable and inadequate at different sites. In FY 2009, Columbia will continue to support
individual sites to continue early case detection, quality case management and follow-up. ICAP will ensure
high quality recording of individual patient information, collect quality data, and to report and review these
data. ICAP will then use program data to understand and improve their program and to support integration
of TB and HIV services at the patient and facility level based on national guidelines.
HIV services are not yet available at all health facilities in Rwanda. Columbia is supporting integrated
planning and TB/HIV training to health care providers including case managers that provide care and
treatment services to patients living with HIV and patients with TB. The training is intended to ensure
effective integration of TB and HIV services and increase the TB case detection rate and accessibility to
comprehensive care and treatment services. Columbia plans on increasing support for integrating
diagnostic services, including coordinating transportation of specimens and patients to referral centers for
appropriate diagnostic services and appropriate follow-up (e.g. chest radiography and extra pulmonary TB
diagnostics). Community health workers will work closely with health care workers to expand access to
health care facilities for early diagnosis and appropriate TB treatment. In FY 2008, 2 staff from each of the
7 supported district hospitals underwent initial respiratory infection control training and each district hospital
has begun drafting infection control plans. In FY 2009 Columbia will support implementation of TB infection
control activities according to the national policy and guidelines.
This activity reflects the ideas presented in the PEPFAR five-year strategy and the Rwandan National
Prevention Plan by advancing the integration of TB/HIV services through the operationalization of policies
and increased coordination of prevention, counseling, screening, testing, care and treatment services.
Lessons learned from integrating TB and HIV will serve in integrating HIV into the existing primary
healthcare system.
Continuing Activity: 12810
12810 4839.08 HHS/Centers for Columbia 6307 129.08 Columbia MCAP $877,438
7180 4839.07 HHS/Centers for Columbia 4329 129.07 Columbia MCAP $37,807
4839 4839.06 HHS/Centers for Columbia 2572 129.06 Columbia MCAP $176,494
Estimated amount of funding that is planned for Human Capacity Development $150,000
Table 3.3.12:
New/Continuing Activity: New Activity
Continuing Activity:
* Addressing male norms and behaviors
* Reducing violence and coercion
Table 3.3.14:
This is a continuing activity from FY 2008.
In FY 2008, Columbia will continue its TA and capacity building activities at NRL by supporting technical
activities as well as strengthening the institutional infrastructure and management capacity critical to sustain
the national network of laboratories for the Rwandan HIV care and treatment program. Direct TA will
continue to be provided through long-term advisors and periodic short-term consultants as needed. Two
long-term technical advisors positions will be continued in FY 2008. The first provides support for HIV-
related quality laboratory services, including evaluations of new technologies, technician trainings, and
guidance on technical and policy issues. The second advisor, a local-hire senior lab technician, will remain
responsible for development and implementation of national standards, QA systems, and training. These
two technical advisors will continue to transfer skills, knowledge and capacity, ensuring a sustained impact.
In FY 2008, Columbia will continue to improve NRL's laboratory management through support of an
international-hire management advisor. The laboratory management advisor will help develop management
systems for finances, logistics, program data, transport and commodities and will mentor the new NRL
Director and Finance position funded under the CDC cooperative agreement. The management advisor
position continues to be critical in strengthening NRL's capacity to effectively manage multiple projects and
multiple streams of funding, including substantial EP resources. Columbia will continue through these
technical and financial positions to support the decentralization of NRL supervision and QA within the
national laboratory network. This decentralization will include continued strengthening of the five regional
district laboratories. PCR for Early Infant Diagnosis and viral load determination will continue to be
supported at NRL and CHUB via equipment maintenance and staff training.
TB services at NRL continue to require strengthening to meet the EP priority of providing reliable AFB
microscopy at the health facility level. Columbia will continue to support laboratory TA to the NRL and
CHUB TB laboratories to ensure high quality smear microscopy, liquid culture and drug sensitivity testing
capability. These TB diagnostic and treatment capabilities are essential in order to provide PLHIV adequate
access to comprehensive quality TB-related services. These capabilities are also essential for the support
of patients with MDR TB. Extrapulmonary TB diagnostics will be available through continued support to
CHUB and CHUK anatomopathology laboratories.
ACM (Atelier central de maintenance) and NRL maintenance units for laboratory equipment will continue to
be strengthened with training and staffing to guarantee the quality of results within the national laboratory
network. Also, small laboratory renovation/rehabilitation will be performed to assure building sustainability
inside the national laboratory network.
Columbia will also continue to strengthen and integrate QA/QC/QI into all HIV-related laboratory areas:
serology, chemistry, hematology, CD4, TB, and malaria. New QA/QC approaches will continue to be
explored in those HIV specific areas. National specimen transportation systems will continue to be
strengthened. Specific laboratory target evaluations on new technical alternatives and new technologies will
be supported to improve the accessibility and reliability of care and treatment programs. For example, new
alternatives technologies will focus on specific HIV areas like, CD4 (dipsticks, micro-chips etc) or TB infants
diagnostics. Protocols and/or indicators should be designed to evaluate laboratory performance impacts on
care and treatment programs.
Columbia will continue to support laboratory staff skills development through local (KHI), regional and
international training programs, with an emphasis on integration of all HIV-related laboratory activities and
total quality management as part of the laboratory accreditation process. In collaboration with CDC,
Columbia will continue to maintain and improve the laboratory information system for NRL and will continue
to support the LIS extension at district hospitals. The laboratory information system will manage financial
record keeping, as well as specimen tracking, inventory control, and programmatic indicators.
All of these activities are consistent with Rwanda's EP five-year strategic goals of strengthening NRL's
capacity to manage a national network of laboratories, standardize technical approaches, and support QA
of HIV-related services throughout the national laboratory network.
Continuing Activity: 12805
27342 27342.06 HHS/Centers for University of 11997 11997.06 University of $500,000
Disease Control & Washington Washington
Prevention
12805 2734.08 HHS/Centers for Columbia 6307 129.08 Columbia MCAP $300,000
7172 2734.07 HHS/Centers for Columbia 4328 93.07 Columbia UTAP $600,000
Disease Control & University
2734 2734.06 HHS/Centers for Columbia 2549 93.06 Columbia UTAP $755,000
Table 3.3.16:
